Recent Advances in Non-Peptidomimetic Dipeptidyl Peptidase 4 Inhibitors: Medicinal Chemistry and Preclinical Aspects

scientific article published on January 1, 2012

Recent Advances in Non-Peptidomimetic Dipeptidyl Peptidase 4 Inhibitors: Medicinal Chemistry and Preclinical Aspects is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2174/092986712802002491
P953full work available at URLhttp://eurekaselect.com/article/download/101107
P698PubMed publication ID22709010

P2093author name stringT. Liu
Y. Hu
Y. Liu
P2860cites workSynthesis of a novel analogue of DPP-4 inhibitor Alogliptin: Introduction of a spirocyclic moiety on the piperidine ringQ42549578
Sulphostin, a potent inhibitor for dipeptidyl peptidase IV from Streptomyces sp. MK251-43F3Q77196519
P433issue23
P407language of work or nameEnglishQ1860
P304page(s)3982-3999
P577publication date2012-01-01
P1433published inCurrent Medicinal ChemistryQ3007710
P1476titleRecent advances in non-peptidomimetic dipeptidyl peptidase 4 inhibitors: medicinal chemistry and preclinical aspects
Recent Advances in Non-Peptidomimetic Dipeptidyl Peptidase 4 Inhibitors: Medicinal Chemistry and Preclinical Aspects
P478volume19

Reverse relations

cites work (P2860)
Q38284522DPP-4 inhibitors: a patent review (2012 - 2014).
Q46415265Design, Synthesis, Biological Evaluation, and Docking Studies of (S)‐Phenylalanine Derivatives with a 2‐Cyanopyrrolidine Moiety as Potent Dipeptidyl Peptidase 4 Inhibitors
Q64107880Discovery of Galangin as a Potential DPP-4 Inhibitor That Improves Insulin-Stimulated Skeletal Muscle Glucose Uptake: A Combinational Therapy for Diabetes
Q46254755Ephedrine as a lead compound for the development of new DPP-IV inhibitors.
Q38221278Novel DPP-4 inhibitors against diabetes
Q36393746SVMDLF: A novel R-based Web application for prediction of dipeptidyl peptidase 4 inhibitors.
Q52688595Structural Dynamics of DPP-4 and Its Influence on the Projection of Bioactive Ligands
Q43951656Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors
Q38205588The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].

Search more.